The Unified Airway Disease: Impact of Upper Airway Treatments on the Lower Airway

Tuesday, October 20, 2026

8:45 AM - 9:45 AM PT

Location: 502A

Moderator(s)

MC

Mohamad R. Chaaban, MD, MSCR, MBA

Associate Professor
Cleveland Clinic
Westlake, Ohio, United States

Panelist(s)

Christine Blanche Franzese, MD

Professor
University of Missouri-Columbia
Columbia, MO, United States
SL

SANDRA Y. LIN, MD

Professor
University of Wisconsin
Madison, WI, United States
KL

KENT K. LAM, MD

Associate Professor
Eastern Virginia Medical School at Old Dominion University
Norfolk, VA, United States

Disclosure(s):

Christine Blanche Franzese, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

KENT K. LAM, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

This panel will review the unified airway concept and examine how medical therapy, biologics, and sinus surgery influence both upper and lower airway disease. Faculty will discuss mechanisms linking sinonasal and pulmonary inflammation and review evidence on asthma and COPD outcomes after upper airway interventions. Attendees will gain practical guidance on integrating treatment strategies across the airway to improve patient outcomes in complex inflammatory disease.

Learning Objectives:

Understand the interconnected pathophysiology of upper and lower airway conditions, including allergic rhinitis, chronic sinusitis, asthma, and COPD.
Evaluate the impact of primary and revision sinus surgery on sinus health and lower airway outcomes, including asthma.
Assess the efficacy and impact of biologic treatments on upper and lower airway diseases based on the latest evidence.